Charlotte’s Web Holdings (CSE:CWEB) announced the appointment of Eugenio Mendez, a former marketing executive with The Coca-Cola Company (NYSE:KO), as the new Chief Growth Officer starting on January 15.
As quoted in the press release:
Mr. Mendez led global strategy and marketing for the division which has annual sales of US$12 billion. Mr. Mendez has also served in an advisory role to Charlotte’s Web for nearly two years. As the Company’s Chief Growth Officer, he will lead the Company’s business development, marketing and sales functions.
“We’re very excited to have Eugenio formally join our Company. Over the past sixteen months, I’ve had the opportunity to work closely with Eugenio and have been deeply impressed with his global vision and experience within the consumer-packaged goods (“CPG”) industry,” said Hess Moallem, President and CEO of Charlotte’s Web. “Eugenio’s appointment illustrates the high caliber executive talent we are attracting to support the Company’s next phase of growth. With the opportunities that exist with national retail partners and anticipated international market expansion, adding top-tier executives with multi-national corporate experience is both timely and opportunistic.”
Charlotte’s Web Chairman and co-founder Joel Stanley stated, “We enthusiastically welcome Eugenio to the executive suite. He is a natural fit for Charlotte’s Web as we continue to evolve and plan for global expansion. As the industry’s leading brand, we will benefit greatly from his marketing experience and leadership.”
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).
Canopy Growth to Participate in BofA Securities Virtual Consumer & Retail Technology Conference on March 11, 2021
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .
Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.
For more information regarding the Company or the offering, please contact email@example.com, or